Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:04 AM UTC
| NCT Number | NCT03848962 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 10,000 participants |
| Active Locations | 2 sites in the US |
| Sponsor | iSpecimen Inc |
| Last Updated on CT.gov | November 9, 2022 (Nov 9, 2022) |
As of July 17, 2026: Clinical trial NCT03848962 is currently recruiting participants. This clinical trial study for cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by iSpecimen Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03848962 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03848962 was last updated Nov 9, 2022 (November 9, 2022). HelloStudys verifies this status automatically.